-
Melinta Therapeutics to Acquire Tetraphase Pharmaceuticals
-
Tetraphase Announces Receipt of Amended Melinta Proposal, Determination of Superior Offer and Notice to AcelRx
-
Tetraphase Announces Second Amendment to Merger Agreement with AcelRx Pharmaceuticals for Increased Consideration
-
Tetraphase Announces Receipt of Amended Melinta Proposal, Determination of Superior Offer and Notice to AcelRx
-
Tetraphase Pharma (TTPH) Announces Amendment to Merger Agreement with AcelRx Pharmaceuticals for Increased Consideration
-
Tetraphase Announces Amendment to Merger Agreement with AcelRx Pharmaceuticals for Increased Consideration
-
Tetraphase Announces Determination of Superior Offer and Notice to AcelRx
-
Tetraphase Pharma (TTPH) and AcelRx Pharmaceuticals (ACRX) Enter into Definitive Merger Agreement
-
Tetraphase Pharmaceuticals and AcelRx Pharmaceuticals Enter into Definitive Merger Agreement
-
Notable Analyst Rating Changes 04/15: (JCP) (CMG) (UA) Upgraded; (UNTK) (ABX) (PAAS) Downgraded

